Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.

TitleFluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.
Publication TypeJournal Article
Year of Publication2004
AuthorsEmslie, GJ, Heiligenstein JH, Hoog SL, Wagner KD, Findling RL, McCracken JT, Nilsson ME, Jacobson JG
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume43
Issue11
Pagination1397-405
Date Published2004 Nov
ISSN0890-8567
KeywordsAdministration, Oral, Adolescent, Child, Depressive Disorder, Double-Blind Method, Female, Fluoxetine, Humans, Male, Placebos, Recurrence, Serotonin Uptake Inhibitors
Abstract

To compare fluoxetine 20 to 60 mg/day with placebo for prevention of relapse of major depressive disorder in children and adolescents who had achieved Children's Depression Rating Scale, Revised scores of < or =28 during treatment with fluoxetine 20 to 60 mg.

DOI10.1016/j.comppsych.2011.05.003
Alternate JournalJ Am Acad Child Adolesc Psychiatry